Synopsis
They can’t sustain the cost,” he said. The supreme court judges have also asked the government’s lawyers why the cap should apply only to cancer drugs and not the entire range of non-patented drugs.
Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.
Read the full story at The Guardian: Health ↗